Skip to main content
CRVW
OTC Manufacturing

CareView Q3 10-Q: Going Concern Reiterated, PDL Maturity Pushed to June 2027

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
8
Price
$0.03
Mkt Cap
$17.692M
52W Low
$0.01
52W High
$0.08
52W Position info
200% above low
Off High info
62% below high
Rel. Volume info
3.8× avg
Market data snapshot near publication time

CRVW has more than doubled off its 52-week low of $0.01 on elevated volume (3.8× avg).

Summary

CareView's Q3 10-Q repeats the going-concern warning with a $45.1M working capital deficit and only $1.9M of cash, while a fresh PDL amendment pushes the loan maturity out to June 30, 2027. Revenue is growing and nine-month operating income turned positive, but interest accruals of $2.4M still swamp it.


Key Events · Earnings and Guidance · CRVW

  • Going Concern Doubt Reiterated

    Management concluded that without additional funding the company will not have sufficient funds to meet its obligations within one year of issuing the financial statements, citing a working capital deficit of $45,121,305 as of September 30, 2026.

  • PDL Maturity Extended to June 2027

    The Seventeenth Amendment, effective October 7, 2026, pushed the PDL credit agreement maturity to June 30, 2027. The September 30, 2026 Sixteenth Amendment, extending it to December 31, 2026, was accounted for as a troubled debt restructuring.

  • Interest Accrual Outruns Operations

    Accrued interest payable reached $25,302,514 against $20,700,000 of principal, with $2,406,375 of interest expense booked over nine months versus operating income of $309,031.

  • Revenue Up, Loss Narrowed

    Nine-month revenue rose to $7,215,317 from $6,682,928, and the net loss narrowed to $2,060,224 from $2,423,724. Q3 alone was a $1,020,361 loss versus $914,214 a year earlier.


Analysis · CRVW · Manufacturing

CareView still cannot fund itself from operations. Management states plainly that without additional funding the company will not have sufficient funds to meet its obligations within one year of issuing these statements, and the balance sheet shows a $45.1M working capital deficit against just $1.9M of cash. The deficit is almost entirely the PDL debt: $20.7M of principal now carries $25.3M of accrued interest that has never been paid in cash — interest expense of $2.4M over nine months is booked, not settled. The one piece of genuine relief is the Seventeenth Amendment signed October 7, 2026, which pushes the PDL maturity to June 30, 2027; that removes the near-term default trigger but is the latest in a chain of short extensions and is accounted for as a troubled debt restructuring, meaning the lender is granting concessions because the borrower cannot pay. Operations are improving at the margin — nine-month revenue rose to $7.2M from $6.7M and operating income turned positive at $309K — but that is nowhere near covering $2.4M of annual interest. The material weakness in technical accounting also persists, so disclosure controls remain ineffective. The equity is deeply out of the money: 583.9M shares outstanding against a $44.6M stockholders' deficit.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CRVW was trading at $0.03 on OTC in the Manufacturing sector, with a market capitalization of approximately $17.7M. The 52-week trading range was $0.01 to $0.08. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CRVW - Latest Insights

CRVW
Aug 12, 2026, 9:36 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0499
Real-time Price: $0.0303 info
Change: -$0.0196 (-39%) info
Market Cap: $17.692M info
CRVW
Jul 01, 2026, 6:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.055
Real-time Price: $0.0303 info
Change: -$0.0247 (-45%) info
Market Cap: $17.692M info
CRVW
May 13, 2026, 2:33 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.035
Real-time Price: $0.0303 info
Change: -$0.0047 (-13%) info
Market Cap: $17.692M info
CRVW
Apr 01, 2026, 6:41 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0302
Real-time Price: $0.0303 info
Change: +$0.0001 (+0.33%) info
Market Cap: $17.692M info
CRVW
Mar 30, 2026, 5:45 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.0302
Real-time Price: $0.0303 info
Change: +$0.0001 (+0.33%) info
Market Cap: $17.692M info